Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1989-07-21
1990-05-22
Howard, Jacqueline V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514557, 514568, 514947, 514960, 514962, A61K 3119
Patent
active
049278541
ABSTRACT:
Sustained and enhanced analgesic response is elicited in a mammalian organism in need of such treatment, i.e., a mammal suffering pain, by administering thereto a unit dosage sustainedly enhancing, analgesically effective amount of the free acid S(+) flurbiprofen enantiomer, said enantiomer being substantially free of its R(-) flurbiprofen antipode.
REFERENCES:
patent: 3637767 (1972-01-01), Alvarez
patent: 3755427 (1973-08-01), Adams et al.
patent: 4439451 (1984-03-01), Coleman
patent: 4440787 (1984-04-01), de Vincentiis
patent: 4443476 (1984-04-01), Lomen
patent: 4486436 (1984-12-01), Sunshine et al.
patent: 4489080 (1984-12-01), Lomen
patent: 4501727 (1985-02-01), Armitage et al.
patent: 4552899 (1985-11-01), Sunshine et al.
patent: 4567183 (1986-01-01), Sunshine et al.
patent: 4619934 (1986-10-01), Sunshine et al.
patent: 4722938 (1988-02-01), Sunshine et al.
"The Metabolic Chiral Inversion of 2-Arylpropionic Acids-A Novel Route with Pharmacological Consequences", J. Pharm. Pharmaco., Andrew J. Hutt et al., vol. 35 (1983), pp. 693-704.
"Naproxen", Anti-Inflammatory and Anti-Rheumatic Drugs, Anthony C. Allison et al., vol. 11, Chapter 9, Ed.: K. D. Rainsford, CRC Press, Inc., Boca Raton, Fla. (1985), p. 172.
"The Importance of Stereochemistry in the Clinical Pharmocokinetics of the 2-Arylpropionic Acid Non-Steroidal Anti-Inflammatory Drugs", Clinical Pharmacokinetics, Andrew J. Hutt et al., vol. 9 (1984), pp. 371-373.
"Anatagonism of Slow Reacting Substance in Anaphylaxis (SRS-A) and Other Spasmogens on the Guinea Pig Trachial Chain by Hydratropic Acids and Their Effects on Anaphylaxis", Journal of Medicinal Chemistry, Margaret E. Greig et al., vol. 18, No. 1 (1975), pp. 112-116.
"Flurbiprofen, A New Potent Inhibitor of Platelet Aggregation", Thrombosis Research, E. E. Nishizawa et al., vol. 3, No. 5 (1973), pp. 577-588.
"Stoichiometry and Kinetics of the Interaction of Prostaglandin H Synthase with Anti-Inflammatory Agents", The Journal of Biological Chemistry, Richard J. Kulmacz et al., vol. 260, No. 23 (Oct. 15, 1985), pp. 12572-12578.
"The Resolution of Enantiomeric Drugs Using HPLC Chiral Stationary Phases", Pharm. Technol., T. D. Doyle et al., vol. 9, No. 2 (1985), pp. 28-32.
"Application of High-Performance Liquid Chromatographic Chiral Stationary Phases to Pharmaceutical Analysis: Structural and Conformational Effects in the Direct Enantiomeric Resolution of Alpha Methylarylacetic Acid Antiinflammatory Agents", J. Chromatogr., I. W. Wainer et al., vol. 284, No. I (1984), pp. 117-124.
"Enantiospecific High-Performance Liquid Chromatographic Analysis of 2-Phenylpropionic Acid, Ketoprofen and Fenoprofen", Journal of Chromatography, B. C. Sallustio et al., vol. 374 (1986), pp. 329-337.
"Gas Chromatographic Separation of Optically Active Anti-Inflammatory 2-Arylapropionic Acids Using (+)- or (-)-Amphetamine as Derivatizing Reagent", J. Chromatogr. Biomed. Appl., N. N. Singh et al., vol. 378, No. 1 (1986), pp. 125-135.
"Isomeric Inversion of Ibuprofen (R)-Enantiomer in Humans", Journal of Pharmaceutical Sciences, D. G. Kaiser et al., vol. 65, No. 2, Feb. 1976, pp. 269-273.
Correspondence relating to study undertaken by Dr. Sunshine at the request of the Boots Company Ltd., 1982-1986.
Laska Eugene M.
Sunshine Abraham
Analgesic Associates
Howard Jacqueline V.
LandOfFree
Sustained/enhanced analgesia does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained/enhanced analgesia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained/enhanced analgesia will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2135220